Clinical trial · Observational
A New Classification System for Lymph Nodes in Colon Cancer: The Prognostic Significance of the Anatomical Distribution of Metastatic Lymph Nodes and the Number of Tumor Deposits
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to investigate the prognostic significance of LNM distribution and establish a new classification system integrating both nodal quantity and anatomical location.The main question it aims to answer is: Does the new N staging based on lymph node metastasis patterns and cancer nodules provide a more accurate prediction of the prognosis of colon cancer patients compared to the AJCC N staging? The relevant clinical characteristics, treatment processes, postoperative pathological data and post-discharge prognosis information of the enrolled patients were collected through the follow-up offices and the medical record system. The data were analyzed. The main research endpoints were: overall survival (the time between the initial surgery and death or the last follow-up); disease-free survival (the time between the initial surgery and disease metastasis, recurrence or death).
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
| Lymph Node Metastases | — | UNRESOLVED | — |
| TNM Staging | — | UNRESOLVED | — |
| Tumor Deposits | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (4)
- label
- No metastasis
- label
- Non-skip metastasis without tumor deposits
- label
- No metastasis or non-skip metastasis with tumor deposits,Skip metastasis without tumor deposits
- label
- Skip metastasis with tumor deposits, All-station metastasis regardless of tumor deposits
Primary outcomes (2)
- measure
- DFS
- timeFrame
- From the date of the initial surgery to death or disease recurrence or metastasis,assessed up to 120 months
- description
- Disease Free Survival
- measure
- OS
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Definite diagnosis of primary colon adenocarcinoma via auxiliary examination or pathology. * No distant metastasis (M0) confirmed by preoperative imaging or intraoperative findings. * No prior neoadjuvant therapy (including chemotherapy, radiotherapy, immunotherapy, or targeted therapy). * Underwent initial radical resection for colon cancer. * Available data on lymph node counts for all three stations. Exclusion Criteria: * Intraoperative or postoperative pathology confirming non-malignant tumors (including carcinoma in Tis). * Multiple primary cancers or concurrent malignancies in other sites.
References
Publications (0)
Data not yet available